NO990450L - Behandling av sinnslidelser - Google Patents

Behandling av sinnslidelser

Info

Publication number
NO990450L
NO990450L NO990450A NO990450A NO990450L NO 990450 L NO990450 L NO 990450L NO 990450 A NO990450 A NO 990450A NO 990450 A NO990450 A NO 990450A NO 990450 L NO990450 L NO 990450L
Authority
NO
Norway
Prior art keywords
treatment
mental disorders
tiagabine
medicament
manufacture
Prior art date
Application number
NO990450A
Other languages
English (en)
Norwegian (no)
Other versions
NO990450D0 (no
Inventor
Anders Fink-Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO990450D0 publication Critical patent/NO990450D0/no
Publication of NO990450L publication Critical patent/NO990450L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO990450A 1996-07-31 1999-01-29 Behandling av sinnslidelser NO990450L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK82496 1996-07-31
PCT/DK1997/000320 WO1998005330A1 (en) 1996-07-31 1997-07-25 Treatment of psychotic disorders

Publications (2)

Publication Number Publication Date
NO990450D0 NO990450D0 (no) 1999-01-29
NO990450L true NO990450L (no) 1999-01-29

Family

ID=8097971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990450A NO990450L (no) 1996-07-31 1999-01-29 Behandling av sinnslidelser

Country Status (18)

Country Link
US (1) US5914333A (hu)
EP (1) EP0920316B1 (hu)
JP (1) JP2000515156A (hu)
KR (1) KR20000029525A (hu)
CN (1) CN1226828A (hu)
AT (1) ATE330604T1 (hu)
AU (1) AU728191B2 (hu)
BR (1) BR9710893A (hu)
CA (1) CA2260863C (hu)
CZ (1) CZ29899A3 (hu)
DE (1) DE69736180T2 (hu)
ES (1) ES2268732T3 (hu)
HU (1) HUP9904030A3 (hu)
IL (1) IL128028A0 (hu)
NO (1) NO990450L (hu)
PL (1) PL331321A1 (hu)
WO (1) WO1998005330A1 (hu)
ZA (1) ZA976854B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
AU8643698A (en) * 1997-08-01 1999-02-22 Elan Corporation, Plc Controlled release pharmaceutical compositions containing tiagabine
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
PT1459750E (pt) * 1999-07-01 2005-08-31 Pharmacia & Upjohn Co Llc (s,s)- reboxetina para tratar a fibromialgia ou outras perturbacoes somatoformes
US6270438B1 (en) * 1999-12-22 2001-08-07 Yuan-Cheng Liao Combination driving hub for bicycle
WO2005000294A1 (en) * 2003-06-06 2005-01-06 Pharmacia Corporation Selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders
US20090139311A1 (en) 2007-10-05 2009-06-04 Applied Biosystems Inc. Biological Analysis Systems, Devices, and Methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
US5767117A (en) * 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
DE69618586T2 (de) * 1995-05-05 2002-09-05 Novo Nordisk As Tiagabinhydrochlorid enthaltendes arzneimittel und verfahren zu dessen herstellung
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
DK174041B1 (da) * 1998-11-26 2002-05-06 Monarflex As Gennemføring til montering i en fleksibel membran

Also Published As

Publication number Publication date
EP0920316B1 (en) 2006-06-21
US5914333A (en) 1999-06-22
DE69736180T2 (de) 2007-06-14
CZ29899A3 (cs) 1999-06-16
CA2260863A1 (en) 1998-02-12
NO990450D0 (no) 1999-01-29
KR20000029525A (ko) 2000-05-25
CA2260863C (en) 2008-02-12
AU3619797A (en) 1998-02-25
ES2268732T3 (es) 2007-03-16
JP2000515156A (ja) 2000-11-14
BR9710893A (pt) 1999-08-17
AU728191B2 (en) 2001-01-04
WO1998005330A1 (en) 1998-02-12
CN1226828A (zh) 1999-08-25
ZA976854B (en) 1998-03-19
HUP9904030A2 (hu) 2000-05-28
DE69736180D1 (de) 2006-08-03
EP0920316A1 (en) 1999-06-09
PL331321A1 (en) 1999-07-05
ATE330604T1 (de) 2006-07-15
IL128028A0 (en) 1999-11-30
HUP9904030A3 (en) 2000-07-28

Similar Documents

Publication Publication Date Title
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
NO20010882L (no) Terapier for behandling av lungesykdommer
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
IL128416A0 (en) Pharmaceutical composition for the treatment of alzheimer's disease
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
DE59310327D1 (de) Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura
NO20056021L (no) Anvendelse av CS-866 til fremstilling av et medikament
LV11666A (lv) Farmaceitiskie preparati un medikamenti endotelialo traucejumu noversanai un arstesanai
NO995245L (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
EP1440689A3 (en) Treatment of neurotic disorders
NO990450L (no) Behandling av sinnslidelser
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
LV11940A (lv) Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas
DE69738320D1 (de) Verwendung von pyrolidin-derivaten zur herstellung von arzneimitteln zur behandlung von drogenmissbrauch
BR0008703A (pt) Utilização da tianeptina para a obtenção de medicamentos destinados ao tratamento das patologias da neurodegenerescência
IT1288399B1 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
HUP0004647A2 (hu) Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
NO970127D0 (no) Topiske sammensetninger for behandling av hudsykdom

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application